The data showed that TGF-β1 induced a similar increase in the production of versican, perlecan, and biglycan in fibroblasts from both COPD patients and control subjects, which suggests that the TGF-β1 response in this respect was not affected. Here, TGFB1 is linked to chronic obstructive pulmonary disease.